Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Cipher Pharmaceuticals Inc. T.CPH

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  CPHMF| CPHR

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops improved formulations of existing drugs. It search for products based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance.
Price: $7.35 | Change: $-0.05 | %Change: -0.68%
Volume: 58,874 | Day High/Low: 7.93/7.22 | 52 Week High/Low: 19.52/7.02
View modes: 
0 stars

RE:RE:RE:Conference call?

Actually Innocutis came with 9 products. At least 3 will contribute significantly to revenue. All 3 are currently generating $2M each a year with limited markerting/sales efforts. What they said on...read more
0 stars

RE:RE:Conference call?

I take it the $1.1Mm of acqn costs 6mos is non-recurring so that helps but they sure are relying on Sitavig when the other 2 current saleable Innocutis' products are declining/competitive and...read more
0 stars

cipher on bnn

in a moment  rate and reply
0 stars

RE:Conference call?

CC transcript: http://seekingalpha.com/article/3440776-cipher-pharmaceuticals-cphr-ceo-shawn-patrick-obrien-discusses-q2-2015-results-earnings-call-transcript?part=single  rate and reply
0 stars

RE:RE:RE:Conference call?

Thanks for the CC summary. Did they say anything in regards to overall 2015 and 2016 numbers?  rate and reply
0 stars

RE:RE:Conference call?

Big takeaways: Profits dampened by acquisition cost (and hidden related costs) of INNOCUTIS.  The tone was a realization that they might have overpaid and had to rectify some problems due...read more
0 stars

RE:Conference call?

YES- IN 2-3 QUARTERS (2) ESPECIALLY... CIPHER WILL BE CLOSER TO 15-20/ SHARE -Nothing wrong here, marketing expenses and other expenses are killing profit at the moment. All for long term momentum...read more
0 stars

Large blocks buying, small ones selling on 19% slide-Buying!

Look at the Time and Sales and you'll see that the large blocks are hitting the ask to accumulate while small amounts are hitting the bid to scare investors out of their shares. That's when you know...read more
0 stars

Conference call?

Anybody listen in?  rate and reply
0 stars

RE:Sub 10 (again)

You wouldn't recognize an opportunity if it slapped you in the face. I am buying like crazy, so far have picked up a bunch under $9.35. If you can look beyond 1Q then you can see the huge opportunity...read more
5 stars

Sub 10 (again)

I tried to warn all you dummies. Lieseeker...u still making money? Ha no chance. This is the worse healthcare stock on the tsx. Anyone who lost money and ignored the countless warning signs, you have...read more
5 stars

RE:RE:RE:Strong into the close - Time to buy again

Yes, looks like that. Certainly more shorting today.  Should have stuck with NHC. Time to bring up at five your chart and draw the uptrend  To see where this may end up.  Ugly for sure  rate and reply
5 stars

RE:RE:Strong into the close - Time to buy again

that was one ugly quarter. This management team does not have anyone's confidence in what they're doing and what they're trying to accomplish. Too much focus on 5 year vision without concern about...read more
0 stars

RE:Strong into the close - Time to buy again

Same here. Will buy between the 10-11 range. A loss of a half a million in Q2 may be just enough to get this into the July low again. Little surprised since last year they had 4.5 million gain and in...read more
0 stars

q ok?

https://ca.finance.yahoo.com/news/cipher-reports-financial-operational-results-110000135.html  rate and reply
0 stars

Strong into the close - Time to buy again

I liked the way CPH rallied into the close even with TSX and Biotech index heading lower. There is definately some quiet accumulation going on and it's no wonder as there are a number of new products...read more
0 stars

RE:looks impossible for big investor to buy without price spike

Liquidity risk is definitely a problem with CPH and RX. The avg daily vol for CPH is under 50k, RX is even worse at under 20k  rate and reply
0 stars

looks impossible for big investor to buy without price spike

It seems some big investors want to buy but it seems difficult to buy a large number of shares without seriously pushing up the stock price.  rate and reply
0 stars

Can we beat $13.00 on this run?

I would not be surprised if another good deal comes out soon. This run started in the USA on the holiday on Monday. With some good news on earngings and with some acquisitions and US investors this...read more
0 stars

RE:Montrusco Bolton Investments

interesting.  Cultivation of American growth investors critical for an ultimate re-rating.  Tone here has gotten too negative IMHO.  The market obviously not believing, or paying attention to Shawn's...read more